Shree Ganesh Biotech (India) surged 9.37% to Rs 164 after the board of the company decided to meet on Monday, 20 December 2021 to approve the stock split.
The board of Shree Ganesh Biotech (India) will meet on Monday, 20 December 2021 approve a 10-for-1 stock split (i.e. sub-division of face value of equity shares of Rs 10 into Rs 1 per equity share).
Shree Ganesh Bio-Tech (India) reported a net profit of Rs 0.82 crore in Q2 FY22 as against a net loss of Rs 0.04 crore in Q2 FY21. Net sales in the second quarter stood at Rs 17.96 crore.
Shree Ganesh Bio-Tech (India) engaged in trading of seeds, tissue culture plant and agriculture seeds. The company operates in plantation of agricultural products segment and produces paddy and potato as high-grade seeds for using in agricultural product. The firm also produces, processes and markets hybrids of crops, such as corn, sunflower, cotton and grain sorghum, among others.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app